Impact of COVID-19 Outbreak on Meningococcal Vaccination, Global Market Research Report 2020

1 Meningococcal Vaccination Market Overview

• 1.1 Product Overview and Scope of Meningococcal Vaccination
• 1.2 Covid-19 Impact on Meningococcal Vaccination Segment by Type
  • 1.2.1 Global Meningococcal Vaccination Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Polysaccharide
  • 1.2.3 Conjugate
  • 1.2.4 Combination
• 1.3 Covid-19 Impact on Meningococcal Vaccination Segment by Application
  • 1.3.1 Meningococcal Vaccination Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Pneumonia
  • 1.3.3 Meningitis
  • 1.3.4 Bacteremia
  • 1.3.5 Others
• 1.4 Covid-19 Impact on Global Meningococcal Vaccination Market Size Estimates and Forecasts
  • 1.4.1 Global Meningococcal Vaccination Revenue 2015-2026
  • 1.4.2 Global Meningococcal Vaccination Sales 2015-2026
  • 1.4.3 Meningococcal Vaccination Market Size by Region: 2020 Versus 2026
• 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.5.2 Covid-19 Impact: Commodity Prices Indices
  • 1.5.3 Covid-19 Impact: Global Major Government Policy
• 1.6 The Covid-19 Impact on Meningococcal Vaccination Industry
• 1.7 COVID-19 Impact: Meningococcal Vaccination Market Trends

2 Covid-19 Impact on Global Meningococcal Vaccination Market Competition by Manufacturers

• 2.1 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Meningococcal Vaccination Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Meningococcal Vaccination Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Meningococcal Vaccination Manufacturing Sites, Area Served, Product Type
• 2.5 Meningococcal Vaccination Market Competitive Situation and Trends
  • 2.5.1 Meningococcal Vaccination Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Meningococcal Vaccination Players (Opinion Leaders)

3 Covid-19 Impact on Meningococcal Vaccination Retrospective Market Scenario by Region

• 3.1 Global Meningococcal Vaccination Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Meningococcal Vaccination Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Meningococcal Vaccination Market Facts & Figures by Country
  • 3.3.1 North America Meningococcal Vaccination Sales by Country
  • 3.3.2 North America Meningococcal Vaccination Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Meningococcal Vaccination Market Facts & Figures by Country
  • 3.4.1 Europe Meningococcal Vaccination Sales by Country
  • 3.4.2 Europe Meningococcal Vaccination Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Meningococcal Vaccination Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Meningococcal Vaccination Sales by Region
  • 3.5.2 Asia Pacific Meningococcal Vaccination Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Meningococcal Vaccination Market Facts & Figures by Country
  • 3.6.1 Latin America Meningococcal Vaccination Sales by Country
  • 3.6.2 Latin America Meningococcal Vaccination Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Meningococcal Vaccination Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Meningococcal Vaccination Sales by Country
  • 3.7.2 Middle East and Africa Meningococcal Vaccination Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Covid-19 Impact on Global Meningococcal Vaccination Historic Market Analysis by Type

• 4.1 Global Meningococcal Vaccination Sales Market Share by Type (2015-2020)
• 4.2 Global Meningococcal Vaccination Revenue Market Share by Type (2015-2020)
• 4.3 Global Meningococcal Vaccination Price Market Share by Type (2015-2020)
• 4.4 Global Meningococcal Vaccination Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global Meningococcal Vaccination Historic Market Analysis by Application

• 5.1 Global Meningococcal Vaccination Sales Market Share by Application (2015-2020)
• 5.2 Global Meningococcal Vaccination Revenue Market Share by Application (2015-2020)
• 5.3 Global Meningococcal Vaccination Price by Application (2015-2020)

6 Company Profiles and Key Figures in Meningococcal Vaccination Business

• 6.1 GlaxoSmithKline
  • 6.1.1 Corporation Information
  • 6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
  • 6.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 GlaxoSmithKline Products Offered
  • 6.1.5 GlaxoSmithKline Recent Development and Response to COVID-19
• 6.2 JN-International Medical
  • 6.2.1 JN-International Medical Corporation Information
  • 6.2.2 JN-International Medical Description, Business Overview and Total Revenue
  • 6.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 JN-International Medical Products Offered
  • 6.2.5 JN-International Medical Recent Development and Response to COVID-19
• 6.3 Novartis International
  • 6.3.1 Novartis International Corporation Information
  • 6.3.2 Novartis International Description, Business Overview and Total Revenue
  • 6.3.3 Novartis International Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Novartis International Products Offered
  • 6.3.5 Novartis International Recent Development and Response to COVID-19
• 6.4 Sanofi
  • 6.4.1 Sanofi Corporation Information
  • 6.4.2 Sanofi Description, Business Overview and Total Revenue
  • 6.4.3 Sanofi Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Sanofi Products Offered
  • 6.4.5 Sanofi Recent Development and Response to COVID-19
• 6.5 Pfizer
  • 6.5.1 Pfizer Corporation Information
  • 6.5.2 Pfizer Description, Business Overview and Total Revenue
  • 6.5.3 Pfizer Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Pfizer Products Offered
  • 6.5.5 Pfizer Recent Development and Response to COVID-19
• 6.6 Baxter International
  • 6.6.1 Baxter International Corporation Information
  • 6.6.2 Baxter International Description, Business Overview and Total Revenue
  • 6.6.3 Baxter International Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Baxter International Products Offered
  • 6.6.5 Baxter International Recent Development and Response to COVID-19
• 6.7 Biomed
  • 6.6.1 Biomed Corporation Information
  • 6.6.2 Biomed Description, Business Overview and Total Revenue
  • 6.6.3 Biomed Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Biomed Products Offered
  • 6.7.5 Biomed Recent Development and Response to COVID-19
• 6.8 Serum Institute of India
  • 6.8.1 Serum Institute of India Corporation Information
  • 6.8.2 Serum Institute of India Description, Business Overview and Total Revenue
  • 6.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Serum Institute of India Products Offered
  • 6.8.5 Serum Institute of India Recent Development and Response to COVID-19

7 Meningococcal Vaccination Manufacturing Cost Analysis

• 7.1 Meningococcal Vaccination Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Meningococcal Vaccination
• 7.4 Meningococcal Vaccination Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Meningococcal Vaccination Distributors List
• 8.3 Meningococcal Vaccination Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Meningococcal Vaccination Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Meningococcal Vaccination by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Meningococcal Vaccination by Type (2021-2026)
• 10.2 Meningococcal Vaccination Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Meningococcal Vaccination by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Meningococcal Vaccination by Application (2021-2026)
• 10.3 Meningococcal Vaccination Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Meningococcal Vaccination by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Meningococcal Vaccination by Region (2021-2026)
• 10.4 North America Meningococcal Vaccination Estimates and Projections (2021-2026)
• 10.5 Europe Meningococcal Vaccination Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Meningococcal Vaccination Estimates and Projections (2021-2026)
• 10.7 Latin America Meningococcal Vaccination Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Meningococcal Vaccination Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List